Literature DB >> 18350445

Strong correlation of B2-microglobulin (B2-m) with procalcitonin (PCT) in the serum of chronic hemodialysis patients: a role for infections in the dialysis-related amyloidosis?

Petros Kalocheretis1, Ioanna Revela, Eleni Spanou, Apostolos Drouzas, Ioanna Makriniotou, Christos Iatrou.   

Abstract

INTRODUCTION: Infections trigger the activation of defensive cells capable to produce and release B(2)-microglobulin (B(2)-m). Procalcitonin (PCT), secreted by a wide range of human cells, included the aforementioned defensive cells, is generally considered a sensitive and specific marker of infection. In this prospective study, we examined the possibility that infections, as detected by increased levels of PCT, increase the serum levels of B(2)-m in chronic hemodialysis (CHD) patients, possibly affecting the rate of progression of dialysis-related amyloidosis (DRA).
METHODS: For a period of four months, 76 CHD patients, 45 men/31 women, mean age 63 +/- 15.7 years, with no residual renal function and in HD for 46 +/- 50 months were studied bimonthly. Blood was drawn, at baseline T(0), two months T(2), and four months T(4), for measuring hematocrit (Ht), white blood cells (WBC), erythrocyte sedimentation rate (ESR), blood urea and serum creatinine, protein (albumin, globulin), C-reactive protein (CRP), and PCT kappa alpha iota B(2)-m. Any events (especially infections) in the preceding 10-day period were recorded.
RESULTS: At baseline, 100% of all B(2)-m measurements were abnormal (>2.4 mg/L), 13.4% of PCT values were increased (>1.5 ng/mL), and 49.4% of CRP values exceeded the lower limit of 5 mg/L with no statistically significant differences between the results of the three periods of the study. Statistically significant, in all periods, was the linear positive correlation of B(2)-m with PCT (T[0]: p < 0.001, T[2]: p < 0.004, T[4]: p < 0.001). Also, statistically significant (p < 0.005) was the positive correlation of B(2)-m to HD vintage.
CONCLUSIONS: In this study, the strong positive correlation of B(2)-m to PCT probably signifies that the (mainly subclinical) infections increase B(2)-m production in CHD patients intensifying the problem of HD-related amyloidosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350445     DOI: 10.1080/08860220701857134

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  5 in total

1.  Plasma calprotectin in chronically dialyzed end-stage renal disease patients.

Authors:  Karin Malícková; Helena Brodská; Jana Lachmanová; Sylvie Dusilová Sulková; Ivana Janatková; Helena Marecková; Vladimír Tesar; Tomás Zima
Journal:  Inflamm Res       Date:  2009-10-25       Impact factor: 4.575

2.  Monoclonal antibodies directed against chicken β2-microglobulin developed with a synthesized peptide.

Authors:  Chuan Yu; Qiu Liu; Wei Gao; Kun Qian; Mei Mei; Hong-Xia Shao; Gen-Hua Wu; Wen-Jie Jin; Ai-Jian Qin
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2013-06

3.  Association of Beta-2 Microglobulin with Inflammation and Dislipidemia in High-Flux Membrane Hemodialysis Patients.

Authors:  Valdete Topçiu-Shufta; Ramë Miftari; Valdete Haxhibeqiri; Shpend Haxhibeqiri
Journal:  Med Arch       Date:  2016-10-25

4.  Diagnostic and prognostic value of procalcitonin for early intracranial infection after craniotomy.

Authors:  Y Yu; H J Li
Journal:  Braz J Med Biol Res       Date:  2017-04-20       Impact factor: 2.590

Review 5.  Chronic inflammation in end-stage renal disease and dialysis.

Authors:  Gabriela Cobo; Bengt Lindholm; Peter Stenvinkel
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.